These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 7346852)

  • 1. Hemodialysis without heparin infusion using Cordis Dow 3500 hollow fiber.
    Raja R; Kramer M; Rosenbaum JL; Bolisay C; Krug M
    Proc Clin Dial Transplant Forum; 1980; 10():39-42. PubMed ID: 7346852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-free hemodialysis with Cuprophan hollow fiber dialyzers by a frequent saline flush, high blood flow technique.
    Agresti J; Conroy JD; Olshan A; Conroy JF; Schwartz A; Brodsky I; Krevolin L; Chinitz J
    Trans Am Soc Artif Intern Organs; 1985; 31():590-4. PubMed ID: 3837514
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful use of a totally heparin grafted hemodialysis system in sheep.
    Schmer G; Teng LN; Cole JJ; Vizzo JE; Francisco MM; Scribner BH
    Trans Am Soc Artif Intern Organs; 1976; 22():654-63. PubMed ID: 951885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of hemodialysis, heparin and protamin on the pre-beta fraction of lipoproteins in patients with chronic kidney failure].
    Koslík S; Takác M; Koslíkova G
    Z Gesamte Inn Med; 1977 Dec; 32(23):658-61. PubMed ID: 204117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Individual dosage schedule of heparin therapy in chronic hemodialysis by analytic studies of blood coagulation].
    Gläser V; Anstadt M
    Z Urol Nephrol; 1990 Mar; 83(3):133-40. PubMed ID: 2356667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the effectiveness of hemodialysis using only heparin or prostacyclin with heparin].
    Kuźniewski M; Sułowicz W
    Przegl Lek; 1990; 47(3):328-31. PubMed ID: 2236625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Heparin-free hemodialysis in chronic patients for temporary management of conditions with a high risk of bleeding].
    Stradtmann H; Förster S; Jalinski W
    Z Urol Nephrol; 1988 Jul; 81(7):449-53. PubMed ID: 3176720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of activated coagulation time for evaluation of the degree of heparinization and calculation of heparin pharmacokinetic parameters during hemodialysis].
    Khodas MIa; Piatnitskaia GKh; Lanskaia IM; Maksimenko VA; Savina ME
    Urol Nefrol (Mosk); 1988; (3):42-8. PubMed ID: 3218006
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of dialyzer geometry on blood coagulation and biocompatibility.
    Lins LE; Boberg U; Jacobson SH; Kjellstrand C; Ljungberg B; Skröder R
    Clin Nephrol; 1993 Nov; 40(5):281-5. PubMed ID: 8281717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heparin dosage in chronic hemodialysis (author's transl)].
    Vogel GE; Hansen W; Goldmann FL; Kopp KF
    Med Klin; 1977 Oct; 72(40):1617-23. PubMed ID: 916946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citrate versus heparin anticoagulation in chronic haemodialysis patients.
    Janssen MJ; Huijgens PC; Bouman AA; Oe PL; Donker AJ; van der Meulen J
    Nephrol Dial Transplant; 1993; 8(11):1228-33. PubMed ID: 8302461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hollow fiber artificial kidney (hfak) dialysis without parenteral heparin.
    Schmer G; Kelly M; Cole J; Vizzo J; Scribner BH
    Proc Clin Dial Transplant Forum; 1973; 3():46-51. PubMed ID: 4808074
    [No Abstract]   [Full Text] [Related]  

  • 13. Short-term hemodialysis with the capillary kidney.
    Stewart RD; Lipps BJ; Baretta ED; Piering WR; Roth DA; Sargent JA
    Trans Am Soc Artif Intern Organs; 1968; 14():121-5. PubMed ID: 5714663
    [No Abstract]   [Full Text] [Related]  

  • 14. Heparin free dialysis: comparative data and results in high risk patients.
    Caruana RJ; Raja RM; Bush JV; Kramer MS; Goldstein SJ
    Kidney Int; 1987 Jun; 31(6):1351-5. PubMed ID: 3613407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Measurement of activated whole blood coagulation as a control parameter for heparin dosage in hemodialysis].
    Kraatz G; Lopot F
    Z Urol Nephrol; 1984 Aug; 77(8):465-71. PubMed ID: 6495895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin elimination and hemostasis in hemodialysis.
    Wilhelmsson S; Lins LE
    Clin Nephrol; 1984 Dec; 22(6):303-6. PubMed ID: 6525772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of heparin anticoagulation for hemodialysis.
    Davenport A
    Hemodial Int; 2011 Oct; 15 Suppl 1():S43-8. PubMed ID: 22093600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of low molecular weight heparin and standard heparin in hemodialysis.
    Bambauer R; Rücker S; Weber U; Köhler M
    ASAIO Trans; 1990; 36(3):M646-9. PubMed ID: 2174689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of coagulation during hemodialysis by a combination of the stable prostacyclin analogue CG 4203 and low-dose heparin.
    Maurin N; Ballmann M
    Clin Nephrol; 1988 Jul; 30(1):35-41. PubMed ID: 3061692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prostacyclin versus regional heparinisation during haemodialysis (author's transl)].
    Hory B; Saunier F; Roy C; Renevier A; Kieffer Y; Saint-Hillier Y; Perol C
    Nouv Presse Med; 1982 Jul 10-17; 11(32):2393-7. PubMed ID: 7050907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.